Otsuka Pharmaceutical Co., Ltd. et al v. Apotex Inc. et al > Summary
Court Case Number 1:24-cv-01004
Filing Date Aug 30, 2024
Court Delaware District Court
Status Unknown
JudgesJennifer L. Hall
Plaintiff Attorneys
10Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Sasha Hoyt
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Erin M. Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Jeanette M. Roorda
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Laura E. Brashear
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Melanie M. Magdun
Finnegan, Henderson, Farabow, Garrett & Dunner
apotex pharmachem india pvt limited
Attorney Name: Greg L. Goldblatt
Rakoczy Molino Mazzochi Siwik
Apotex
Attorney Name: Joseph T. Jaros
Rakoczy Molino Mazzochi Siwik
Defendant Attorneys
5Aposherm Delaware Holdings Corporation
Attorney Name: John C. Phillips Jr.
Phillips, McLaughlin & Hall, P.A.
Aposherm Delaware Holdings Corporation
Attorney Name: Dylan G. Sacenti
Rakoczy Molino Mazzochi Siwik
Aposherm Delaware Holdings Corporation
Attorney Name: Megan C. Haney
Phillips, McLaughlin & Hall, P.A.
Apotex
Attorney Name: Sarah M. L. Wilkening
Rakoczy Molino Mazzochi Siwik
Aposherm Delaware Holdings Corporation
Attorney Name: William A. Rakoczy
Rakoczy Molino Mazzochi Siwik
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11648347 | Medical device containing a cake composition comprising aripiprazole as an active ingredient, and a cake composition comprising aripiprazole as an active ingredient | May 16, 2023 |
| 11400087 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Aug 2, 2022 |
| 11344547 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | May 31, 2022 |
| 11154553 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Oct 26, 2021 |
| 10980803 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Apr 20, 2021 |
| 10525057 | Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Jan 7, 2020 |
